OBJECTIVES: Shoulder spasticity after stroke or traumatic brain injury (TBI) may cause pain and restrict joint range of motion (ROM). Few studies have investigated botulinum toxin injections into shoulder muscles for spasticity treatment. Here we present data for sub-populations of patients receiving shoulder injections of abobotulinumtoxinA in two international, multicentre clinical studies: phase-4 ULIS-II (Upper Limb International Spasticity Study-II; post-stroke spasticity; NCT01020500) study, and phase-3 AUL open-label (Adult Upper Limb; post-stroke or -TBI spasticity; NCT01313299) study. METHODS: We present data for abobotulinumtoxinA shoulder-injected subpopulations. ULIS-II: selection and achievement of patient-centred primary goals. AUL study: Tardieu scale for passive ROM (XV1), angle of catch (XV3) and spasticity angle (X) for shoulder muscles; and Modified Frenchay Scale (MFS) for active function. RESULTS: In ULIS-II, 82 patients received abobotulinumtoxinA in shoulder mu...
